| |
Sustained reduction of HBV DNA, RNA and proteins, and HBeAg seroconversion in a chronically HBV-infected chimpanzee treated with nucleoside analog/ARC-520 combination therapy
|
| |
| |
Reported by Jules Levin
HEPDART 2015
December 6-10, 2015 Wailea, HI
Christine I. Wooddell1, Deborah Chavez2, Jason E. Goetzmann3, Ryan M. Peterson1, Zhao Xu1, Robert G. Gish4,5, Stephen A. Locarnini6, Christopher R. Anzalone1, Robert E. Lanford2 and David L. Lewis1
1 Arrowhead Research Corporation, Madison, WI; 2 Texas Biomedical Research Institute, San Antonio, TX; 3 University of Louisiana, Lafayette, LA; 4 Stanford University Medical Center, Palo Alto, CA;
5 Hepatitis B Foundation, Doylestown, PA; 6 Victorian Infectious Diseases Reference Laboratory, Melbourne, Australia
|
|
| |
| |
|
|
|
